Unlocking true 3D cell culture

Our biomimetic Synmatrix hydrogels provide an optimized extracellular matrix, enabling enhanced cell viability, spreading, and reproducibility in 3D culture systems.

Why choose us?


 

3D Models for Physiological Relevance

Replicating native human tissue architecture with organ-on-a-chip platforms, delivering more predictive and physiologically relevant results for drug discovery and disease modeling.

Optimized Hydrogels for 3D Cell Culture

Our hydrogels ensure unmatched batch-to-batch consistency, high cytocompatibility, and superior performance for primary cells, iPSCs, and organoids in 3D culture systems.

A Decade of Organ-on-a-Chip Expertise

With over 10 years of OOC innovation, we provide fully customized solutions—from microfluidic chip design to integrated perfusion systems—tailored to accelerate your research.

Our Core Products

Cutting-edge Tools for 3D Biology

From hydrogels to organ-on-a-chip systems, our products empower next-generation cell culture, modeling, and drug discovery.

Hydrogels

  • GelMA & HAMA bioinks for 3D culture
  • Batch-to-batch consistency
  • High cytocompatibility
  • Synmatrix Gel support iPSCs, primary cells, organoids

Organ-on-a-chip

  • Integrated tissue culture with perfusion
  • Real-time monitoring compatibility
  • Physiological relevance close to in vivo
  • Proven applications in disease models

Mircofluidic chip

  • Customizable microchannel design
  • Optical & fluidic compatibility
  • For single- & multi-organ modeling
  • Scalable for drug testing

Customized products

  • Tailored chip design & hydrogel kits
  • Integration with lab hardware
  • Consulting & training support
  • Full-stack R&D service
Innovators Behind NEOgran

OUR SCIENTIFIC FOUNDERS

Combining science, engineering, and vision to drive innovation.

Robin Wu

CTO, co-founder
Principal Investigator Marie Skłodowska-Curie Actions (MSCA) Fellow 15 years expertise in Biomaterials and Organ-on-a-chip.

Jaking Tang

Co-founder

hiPSCs research
Extensive publication record in hiPSCs and tissue engineering.

Ling Wang

CEO, co-founder
10 years expertise in materials–cell interactions
Specialist in strategy, partnerships, and industry translation.
World-Class Advisory Team

OUR ADVISOR BOARD

From scientific discovery to market transformation.

Terry Pollard (Oxford)

Strategic Advisor
Brings 20+ years of experience building and scaling science-driven ventures, guiding NEOgran with strategic leadership, commercialization expertise, and investment readiness.

Prof. Kejia Hu (Oxford)

AI Strategy & Implementation

Advises on AI strategy and human-algorithm collaboration, ensuring our models are designed for practical impact and intelligent data-driven decision making.

Prof. Wang Xi (CNRS)

Scientific Advisor
Supports NEOgran with expertise in cell mechanics and biophysical systems, strengthening our research foundation and biological model validation.

We are waiting for your questions!

We are always open to you, feel free to communicate with our team